[NVIC] Mandated Ebola Vaccine Someday?

[Guest guest]

E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#9119

* * * * * * * * * * * * * * * * * * * * * * *

" Protecting the health and informed consent rights of children since 1982. "

============================================================================

==============

BL Fisher Note:

The way the pharmaceutical industry funds and government health agencies

provide affordable vaccines to Third World populations is for populations in

the U.S. and Europe to purchase vaccines at full price and use them on a

mass basis. Ebola may not be a problem in the U.S. or Europe (although CDC

officials are fond of reminding everyone on a daily basis that deadly

disease is just a " plane ride " or terrorist plot away) but when an ebola

vaccine is developed, the most likely scenario will be that it will be

mandated in countries that don't need it to pay for getting it to countries

which do.

http://au.biz./050414/21/439j.html

Fianance, Australia

Crucell and NIH Sign 21.4 Million Ebola Vaccine Manufacturing Contract

Thursday April 14, 2005, 4:17 pm

LEIDEN, Netherlands, April 14, 2005 (PRIMEZONE) -- Dutch biotechnology

company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it

has signed a manufacturing contract with the Vaccine Research Center (VRC),

part of the National Institute of Allergy and Infectious Diseases (NIAID) of

the National Institutes of Health (NIH), for the manufacture of vaccines

against Ebola infections.

Under the terms of the contract, Crucell will manufacture up to ten batches

of clinical material of the PER.C6®-based Ebola vaccine in its own

manufacturing facility. These materials will be used for Phase I and early

Phase II clinical studies in humans. Crucell will receive up to 21.4 million

(US$ 27.6 million) from the VRC for the manufacturing of these clinical

lots.

" We are pleased to have continued the expansion of our relationship with the

VRC on the development of this novel vaccine against bioterrorism, " said

Crucell's Chief Scientific Officer, Jaap Goudsmit.

About Crucell

Crucell N.V. is a biotechnology company focused on developing vaccines and

antibodies that prevent and treat infectious diseases, including Ebola,

influenza, malaria, West Nile virus and rabies. The company's development

programs include collaborations with Sanofi Pasteur for influenza vaccines,

the U.S. National Institutes of Health for Ebola and malaria vaccines, and

GlaxoKline (GSK), Walter Army Institute of Research and New York

University for a malaria vaccine. Crucell's products are based on its

innovative PER.C6® technology, which offers a safer, more efficient way to

produce biopharmaceuticals. The company licenses its PER.C6® technology to

the biopharmaceutical industry on a mostly non-exclusive basis. Licensees

and partners include DSM Biologics, GSK, Centocor/J & J and Merck & Co., Inc.

Crucell is headquartered in Leiden, The Netherlands, and is listed on the

Euronext and NASDAQ stock exchanges (ticker symbol CRXL). For more

information, please visit www.crucell.com.

This press release contains forward-looking statements that involve inherent

risks and uncertainties. We have identified certain important factors that

may cause actual results to differ materially from those contained in such

forward-looking statements. For information relating to these factors please

refer to our Form 20-F, as filed with the U.S. Securities and Exchange

Commission on February 27, 2004, and the section entitled " Risk Factors " .

The company prepares its financial statements under generally accepted

accounting principles in the United States (U.S. GAAP).

Click here for a PDF version of this press release:

http://hugin.info/132631/R/989152/148350.pdf

----

=============================================

News@... is a free service of the National Vaccine Information

Center and is supported through membership donations. Learn more about

vaccines, diseases and how to protect your informed

consent rights http://www.nvic.org

Become a member and support NVIC's work

https://www.909shot.com/Making%20Cash%20Donations.htm

To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm